News
Eli Lilly Shares Up 13% After Weight Loss Pill Appears As Effective As Ozempic And Mounjaro In Trials
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily weight loss pill, orforglipron, demonstrated effectiveness consistent with other injectable GLP-1 weight loss drugs, such as Lilly’s Mounjaro and Novo Nordisk’s Ozempic.
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
Weight loss supplements, when not backed with a healthy diet and strength training, can have side-effects on the body.
A DAILY weight loss pill that works like Ozempic has succeeded in a major clinical trial for the first time. Patients lost an ...
Pfizer will end development of weight-loss pill over fears about its impact to the liver - The drugmaker said the patient’s ...
The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...
SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike GLP-1 drugs, which are administered via injection and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback